Congestive Heart Failure | Clinical Medicine

Ninja Nerd
11 Mar 202458:20

Summary

TLDRThis video script delves into the clinical aspects of heart failure, distinguishing between left and right heart failure and high-output failure. It discusses the pathophysiology, causes, and complications associated with each type, highlighting the importance of left ventricular ejection fraction and the role of systemic vascular resistance. The script also covers the diagnostic approach and treatment strategies, including medication therapy, device therapy, and potential transplant considerations for severe cases, aiming to reduce mortality and improve patient outcomes.

Takeaways

  • 🚑 **Heart Failure Overview**: The script discusses heart failure, covering its types, pathophysiology, and clinical aspects within clinical medicine.
  • 📈 **Pathophysiology of Heart Failure**: It differentiates between left heart failure, right heart failure, and high-output failure, detailing the pathophysiological processes behind each type.
  • 🔍 **Systolic vs. Diastolic Heart Failure**: The script explains the differences between systolic heart failure (reduced contractility and ejection fraction) and diastolic heart failure (difficulty filling the heart with preserved ejection fraction).
  • 💊 **Causes of Heart Failure**: It identifies common causes of heart failure, such as myocardial infarction, cardiomyopathies, and aortic stenosis, which affect the heart's ability to pump blood effectively.
  • 📉 **Ejection Fraction Importance**: The left ventricular ejection fraction (LVEF) is highlighted as a critical measure, with a reduced LVEF indicating systolic heart failure (HFrEF) and a preserved LVEF indicating diastolic heart failure (HFpEF).
  • 🌡️ **Compensatory Mechanisms**: The body's compensatory mechanisms, such as the renin-angiotensin-aldosterone system and sympathetic nervous system activation, are explained in response to reduced cardiac output.
  • 💔 **Complications of Heart Failure**: The script outlines complications of heart failure, including pulmonary edema, cardiogenic shock, and organ malperfusion due to decreased systemic perfusion.
  • 🩺 **Diagnosis of Heart Failure**: It describes the diagnostic approach to heart failure, including the use of chest X-rays, BNP levels, echocardiograms, and right heart catheterization.
  • 🛠️ **Treatment Strategies**: The script covers the treatment of heart failure, emphasizing guideline-directed medical therapy, device therapy, and the use of inotropes and mechanical circulatory support in severe cases.
  • 🛑 **Acute Decompensation**: It discusses the management of acute decompensated heart failure, including the use of diuretics, BiPAP, and the consideration of mechanical support such as ECMO and LVADs.
  • 🏥 **Patient Management**: The importance of a systematic approach to patient management in heart failure, from risk factor modification to advanced therapies like cardiac transplantation, is emphasized.

Q & A

  • What is the main focus of the video script?

    -The main focus of the video script is to discuss heart failure, covering its types, pathophysiology, causes, and the different aspects of left and right heart failure.

  • What are the two primary subtypes of left heart failure mentioned in the script?

    -The two primary subtypes of left heart failure mentioned are systolic heart failure and diastolic heart failure.

  • What is systolic heart failure?

    -Systolic heart failure occurs when there is a reduction in the contractility of the left ventricular myocardium, often caused by conditions such as myocardial infarction, dilated cardiomyopathy, or myocarditis, leading to a drop in left ventricular ejection fraction (LVEF).

  • What does LVEF stand for and why is it important in systolic heart failure?

    -LVEF stands for Left Ventricular Ejection Fraction, which is the amount of blood pumped out of the heart with each contraction. It is important in systolic heart failure because a reduced LVEF indicates poor contractility and is used to diagnose heart failure with reduced ejection fraction (HFrEF).

  • What are the common causes of diastolic heart failure?

    -Diastolic heart failure is commonly caused by conditions that increase afterload, such as chronic hypertension and aortic stenosis, leading to left ventricular hypertrophy and difficulty in filling the ventricle.

  • How does high output heart failure differ from typical heart failure?

    -High output heart failure is characterized by increased cardiac output due to systemic vasodilation, which, despite the high output, is not sufficient to meet the body's oxygen demands, leading to tissue hypoperfusion.

  • What are the potential complications of heart failure mentioned in the script?

    -The potential complications of heart failure include pulmonary congestion, pulmonary edema, cardiogenic shock, organ malperfusion, and the development of conditions such as hypoxia, acute kidney injury (AKI), and lactic acidosis.

  • What is the role of the renin-angiotensin-aldosterone system (RAAS) in heart failure?

    -The RAAS plays a significant role in the compensatory mechanisms during heart failure. Activation of the RAAS increases systemic vascular resistance (SVR) and promotes sodium and water retention, which can worsen heart failure by increasing preload and afterload.

  • What are some of the treatment strategies for heart failure discussed in the script?

    -Treatment strategies for heart failure include the use of medications like ACE inhibitors, ARBs, beta-blockers, diuretics, aldosterone antagonists, and sglt2 inhibitors. Other treatments involve device therapies such as CRT, ICDs, and LVADs, and in severe cases, the use of inotropes or mechanical circulatory support like ECMO.

  • How does the body compensate for decreased cardiac output in heart failure?

    -The body compensates for decreased cardiac output by increasing systemic vascular resistance (SVR) through the activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system, which can lead to vasoconstriction and fluid retention.

  • What diagnostic tools are used to assess heart failure according to the script?

    -Diagnostic tools used to assess heart failure include chest X-ray, B-type natriuretic peptide (BNP) levels, echocardiogram, EKG, and in more severe cases, right heart catheterization to measure pulmonary capillary wedge pressure.

Outlines

00:00

📚 Introduction to Heart Failure

The video script begins with an introduction to heart failure, discussing its relevance in clinical medicine. The speaker encourages viewers to support the content through likes, comments, and subscriptions. Additional resources such as notes and illustrations are available on their website. An upcoming course for the USMLE Step 2 and merchandise are also promoted. The script then delves into the pathophysiology of congestive heart failure (CHF), distinguishing between left heart failure, right heart failure, and high-output failure, with a focus on the most common type, left heart failure, and its two subtypes: systolic and diastolic heart failure.

05:02

💓 Understanding Left Heart Failure

This paragraph delves deeper into left heart failure, explaining the difference between systolic and diastolic heart failure. Systolic heart failure occurs when there is a reduction in the contractility of the left ventricle, often due to myocardial infarction, dilated cardiomyopathy, or myocarditis. The decrease in contractility leads to a drop in the left ventricular ejection fraction (LVEF), causing forward flow issues. Diastolic heart failure, on the other hand, is characterized by difficulties in filling the left ventricle due to high afterload, often caused by chronic hypertension or aortic stenosis. The script also discusses the implications of these conditions on cardiac output and the compensatory mechanisms of the body.

10:02

🔄 Compensatory Mechanisms and Their Effects

The script explains the body's compensatory mechanisms in response to decreased cardiac output, such as the activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system. These mechanisms aim to increase systemic vascular resistance (SVR) to maintain blood pressure, but they can exacerbate heart failure by causing vasoconstriction, increased afterload, and promoting ventricular hypertrophy. The release of atrial natriuretic peptide (ANP) by the heart in response to stretch is also discussed as a compensatory mechanism to counteract the effects of angiotensin II.

15:04

👉 Right Heart Failure and High Output Failure

The script moves on to describe right heart failure, which is often a result of reduced contractility due to conditions like right ventricular MI or increased afterload due to pulmonary hypertension. The consequences of these issues include dilated and hypertrophied right ventricles, leading to a decrease in right ventricular filling and cardiac output. High output heart failure is also introduced as a rare condition where systemic vascular resistance is low, leading to increased cardiac output that is still insufficient to meet the body's demands.

20:05

🚨 Complications of Heart Failure

This section outlines the complications associated with heart failure, focusing on left heart failure. Complications include pulmonary congestion, pulmonary edema, and the associated symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea. Severe cases can lead to acute decompensated heart failure, which may cause severe pulmonary edema, hypoxia, and increased work of breathing. The script also touches on cardiogenic shock as a critical complication of heart failure.

25:06

🛑 Advanced Complications and Presentations

The script further discusses the advanced complications of heart failure, including the effects of decreased systemic perfusion on various organs. It mentions the potential for encephalopathy, myocardial infarction, acute kidney injury (AKI), and acute mesenteric ischemia. The development of lactic acidosis due to poor tissue perfusion is also highlighted. Additionally, the script describes the signs of right heart failure, such as jugular venous distension, pitting edema, hepatic congestion, and ascites.

30:07

🏥 Diagnosis and Treatment of Heart Failure

The final paragraph covers the diagnostic approach to heart failure, including the use of chest X-rays, B-type natriuretic peptide (BNP) levels, echocardiograms, and right heart catheterization. It emphasizes the importance of physical examination and the consideration of acute left heart failure in the presence of elevated BNP levels, pulmonary capillary wedge pressure, and suggestive chest X-ray findings. The treatment approach involves guideline-directed medical therapy, which includes the use of ACE inhibitors, ARBs, beta-blockers, diuretics, aldosterone antagonists, and sglt2 inhibitors. The script also mentions alternative therapies and device therapies such as CRT, ICDs, and LVADs, as well as the use of inotropes and mechanical circulatory support in cardiogenic shock.

Mindmap

Keywords

💡Heart Failure

Heart failure is a chronic condition where the heart is unable to pump blood effectively, meeting the body's needs for circulation. It is central to the video's theme, as the script discusses various types, causes, and consequences of heart failure. The video differentiates between left and right heart failure, as well as high-output heart failure, providing examples such as reduced contractility and increased afterload.

💡Systolic Heart Failure

Systolic heart failure refers to a condition where the heart's ability to contract is compromised, often due to a decrease in left ventricular contractility. It is a key concept in the script, used to explain scenarios like myocardial infarction leading to fibrosis and reduced ejection fraction, exemplified by the term 'HFrEF' (Heart Failure with Reduced Ejection Fraction).

💡Diastolic Heart Failure

Diastolic heart failure is characterized by difficulty in the heart's filling phase, not its pumping phase. The script explains it as a common type where the left ventricle becomes hypertrophied, reducing its ability to fill with blood. This concept is integral to understanding heart failure with preserved ejection fraction.

💡Ejection Fraction

Ejection fraction is a measure of how efficiently the heart pumps blood with each beat. The script discusses its importance in diagnosing heart failure, mentioning that a reduced left ventricular ejection fraction (less than 40%) is indicative of systolic heart failure.

💡Cardiac Output

Cardiac output is the volume of blood pumped by the heart per minute. The video script explains how a decrease in cardiac output is a central issue in systolic heart failure, while in diastolic heart failure and high-output heart failure, the cardiac output is affected differently due to various pathophysiological mechanisms.

💡Afterload

Afterload refers to the resistance against which the heart muscle must contract to eject blood. In the context of the script, it is a critical factor in diastolic heart failure, where conditions like aortic stenosis or chronic hypertension increase afterload, making it difficult for the heart to pump blood.

💡Renin-Angiotensin-Aldosterone System (RAAS)

The renin-angiotensin-aldosterone system is a hormone system that regulates blood pressure and fluid balance. The script describes how in heart failure, activation of the RAAS system can lead to increased systemic vascular resistance and fluid retention, exacerbating the condition.

💡Pulmonary Edema

Pulmonary edema is the buildup of fluid in the lungs, often a complication of heart failure. The script discusses how it occurs due to high pressure in the pulmonary veins and capillaries, leading to fluid leakage into the lung tissue, which is a critical sign of left heart failure.

💡Cardiogenic Shock

Cardiogenic shock is a severe form of heart failure where the heart cannot pump enough blood to meet the body's needs. The script mentions it as a potential complication of both left and right heart failure, characterized by low cardiac output and systemic hypoperfusion.

💡Compensatory Mechanisms

Compensatory mechanisms in the script refer to the body's responses to maintain blood pressure and perfusion when cardiac output is reduced. These include increased systemic vascular resistance and activation of the sympathetic nervous system, which can have adverse effects in heart failure.

💡Diuretics

Diuretics are medications that increase urine production, helping to reduce fluid buildup and lower blood pressure. The script discusses their use in treating heart failure to alleviate symptoms of congestion and edema by promoting the excretion of excess fluid.

💡Cardiac Resynchronization Therapy (CRT)

Cardiac resynchronization therapy, mentioned in the script, is a treatment for heart failure that uses a pacemaker to improve the coordination of the heart's pumping action. It is particularly beneficial for patients with a left ventricular ejection fraction below a certain threshold and a specific type of heart conduction delay.

💡Left Ventricular Assist Device (LVAD)

An LVAD is a mechanical device that helps a failing heart pump blood. The script discusses it as a potential therapy for patients with severe heart failure who are not responding to other treatments, possibly serving as a bridge to a heart transplant.

Highlights

Introduction to the topic of heart failure within clinical medicine.

Discussion of different types of heart failure: left, right, and high-output failure.

Explanation of systolic heart failure, its causes, and the impact on left ventricular function.

Causes of systolic heart failure including myocardial infarction and dilated cardiomyopathy.

Importance of left ventricular ejection fraction (LVEF) in diagnosing systolic heart failure.

Description of diastolic heart failure, its causes, and the role of afterload in the condition.

Mention of chronic hypertension and aortic stenosis as common causes of diastolic heart failure.

Differences between systolic and diastolic heart failure in terms of ventricular changes and ejection fraction.

Compensatory mechanisms of the body in response to low cardiac output in heart failure.

Role of the renin-angiotensin-aldosterone system in heart failure and its therapeutic implications.

Potential complications of heart failure, including pulmonary edema and cardiogenic shock.

Diagnostic approach to heart failure, including the use of chest X-ray, EKG, and echocardiogram.

Treatment strategies for heart failure, focusing on guideline-directed medical therapy.

Use of device therapy such as CRT, ICD, and LVAD in advanced heart failure management.

Management of cardiogenic shock, including the use of inotropes and mechanical circulatory support.

Importance of patient education and support, as well as the development of course materials for medical students.

Transcripts

play00:02

foreign

play00:07

ERS in this video today we're going to

play00:09

be talking about heart failure this is

play00:10

going to be again within our clinical

play00:12

medicine section if you guys really like

play00:14

this video and this helps you please

play00:15

support us by hitting that like button

play00:17

comment down the comment section and

play00:18

most importantly subscribe also if you

play00:21

guys want some great notes some great

play00:22

illustrations to follow along with go

play00:24

down the description box below check out

play00:25

our link it'll take you to our website

play00:26

we have a lot of great stuff there also

play00:27

if you guys are interested we are

play00:29

actually developing a course for the US

play00:31

Emily Step 2 and pants that'll cover all

play00:33

of this in great detail go check that

play00:35

out as well and check out the merch we

play00:37

got some great stuff please go to our

play00:39

website check out all this stuff get

play00:41

yourself some swag all right let's start

play00:43

talking a little bit about CHF or heart

play00:46

failure congestive heart failure many

play00:47

different terminologies there

play00:49

we talk about heart failure the first

play00:51

thing we want to talk about is the

play00:52

pathophysiology behind it

play00:54

and really there's a couple different

play00:55

types of heart failure believe it or not

play00:57

there's left heart failure right heart

play00:58

failure and this weird one called high

play01:01

output failure we're going to talk first

play01:03

about left heart failure which is going

play01:04

to be by far the most common type of

play01:06

heart failure

play01:07

now we talk about left heart failure we

play01:10

want to think about two different types

play01:12

or subtypes if you will of left heart

play01:14

failure there's what's called systolic

play01:16

heart failure and diastolic heart

play01:18

failure now what would cause this

play01:21

patient was a normal heart to start

play01:22

diverting its way into developing

play01:24

systolic heart failure the primary

play01:26

reason why this would develop is a

play01:29

patient would have a reduction

play01:31

in their contractility so the

play01:34

contractility of the left ventricular

play01:36

myocardium is going down so there's a

play01:39

drop in the contractility so then you

play01:41

have to ask yourself the question what

play01:44

is causing this left ventricular

play01:45

myocardium to not contract what are the

play01:48

disease processes which would lead to

play01:50

this so here we're going to say that

play01:51

this myocardium here this left

play01:53

ventricular myocardium is damaged in

play01:55

some way shape or form and the

play01:57

contractility here is knocked down

play01:58

what's some causes

play02:00

one of the most common causes here by

play02:03

far is going to be a myocardial

play02:05

infarction if a patient had an MI it's

play02:07

going to cause fibrosis of that tissue

play02:09

do you lose you lose contractility there

play02:11

that's one way

play02:12

another one believe it or not is

play02:14

cardiomyopathies you know which one

play02:16

particularly is very very commonly

play02:18

associated with this one it's called

play02:20

dilated

play02:21

cardiomyopathy because what happens is

play02:23

the the actual ventricles get really

play02:25

really thin and very weak that's another

play02:27

one where the contractility goes down

play02:29

another one could be myocarditis but

play02:32

it's relatively uncommon but we'll put

play02:34

that one down as well so another one

play02:36

could be myocarditis so inflammation of

play02:39

the myocardium but all of these things

play02:41

would be stimulatory factors that could

play02:44

lead to systolic heart failure where the

play02:46

contractility is just not good if the

play02:50

contractility of the heart is not good

play02:51

particularly left ventricle can it push

play02:54

blood out of the left ventricle and into

play02:57

the aorta very well no and so this is

play03:00

where the issue occurs is that the

play03:02

patient has a hard time being able to

play03:04

pump blood out of the heart

play03:06

so it's a problem with forward flow

play03:09

there's a very important kind of like

play03:11

formula we're not going to go crazy into

play03:12

it but it helps us determine something

play03:14

called the left ventricular ejection

play03:16

fraction and this is a very important

play03:18

terminology so in this person who has

play03:21

systolic heart failure sometimes what

play03:23

happens is as you drop the contractility

play03:27

as you drop the contractility you drop

play03:30

What's called the left ventricular

play03:32

ejection fraction which is basically the

play03:35

amount of blood that you're able to pump

play03:37

out of the heart right and so when this

play03:40

happens a decrease in left the

play03:41

contractility when that happens that

play03:44

goes down you drop your left ventricular

play03:46

ejection fraction

play03:47

and now it's hard being able to get

play03:49

blood out of the heart

play03:51

when that happens

play03:53

what we do is we have a very specific

play03:55

terminology whenever the patient has a

play03:57

reduced left ventricular ejection

play03:59

fraction particularly particularly when

play04:01

it's less than 40 percent you know we

play04:03

call that we call that heart failure

play04:06

with a reduced ejection fraction we call

play04:09

this hefref and that's usually when it's

play04:12

less than

play04:13

40 percent so when the left ventricular

play04:16

ejection fraction is less than 40 we

play04:18

call that hefref which is a another way

play04:20

of describing systolic heart failure

play04:23

but the whole point here that I want you

play04:24

to understand is can contractilities

play04:26

down the amount of blood getting out of

play04:28

the heart is down so what is that called

play04:31

when the volume of blood that you're

play04:32

supposed to be pumping out of the heart

play04:34

and one minute goes down that's cardiac

play04:37

output

play04:38

so in these patients they will start to

play04:40

experience a drop in there cardiac

play04:43

output which we're going to abbreviate

play04:44

Co

play04:45

and that's the big highlighting Factor

play04:47

here for systolic heart failure or

play04:49

hefref heart failure where the reduced

play04:51

ejection fraction their causes dropping

play04:53

contractility due to these can diseases

play04:56

now

play04:58

when we come over here to the other

play04:59

flavor of left heart failure diastolic

play05:01

heart failure this is another really

play05:03

really common one

play05:04

the problem here is something different

play05:06

in the sense that it is really hard to

play05:10

get blood out of the heart

play05:13

and there's a couple ways that blood

play05:15

leaves the heart right so we call that

play05:16

like stroke volume the amount of blood

play05:18

that you're kind of getting out of the

play05:18

heart and one heartbeat that's dependent

play05:20

upon preload contractility and what's

play05:22

the last one afterload

play05:25

when the afterload is crazy high in

play05:27

these patients it's hard for them to get

play05:29

blood out of the heart and that's

play05:31

usually the problem here is that these

play05:33

patients develop a massive

play05:35

increase in their afterload

play05:39

what are diseases

play05:41

that would really kind of increase the

play05:44

afterload and cause these particular

play05:45

types of problems

play05:47

chronic hypertension can't say how

play05:49

common that particular etiology is that

play05:52

is probably going to be by far one of

play05:53

the most common causes so this would be

play05:55

a chronic

play05:58

hypertension we'll put chronic here

play06:01

what's another one you know there's a

play06:03

valve right here right there's a valve

play06:06

right here called the aortic valve

play06:08

aortic semilunar valve what if that

play06:10

valve is super super stonotic and

play06:13

because it's crazy crazy snotic it's

play06:15

almost hard it's kind of obstructing the

play06:17

forward flow that would also cause a lot

play06:19

of afterload aortic stenosis is another

play06:21

really common cause here so another

play06:23

disease would be called aortic

play06:26

stenosis this is another very very

play06:28

common cause for an increase in

play06:30

afterload it's basically anything that's

play06:32

going to make it harder for the blood to

play06:33

get out of the left ventricle these two

play06:36

things

play06:36

by far are going to be the most common

play06:39

thing that will cause diastolic heart

play06:40

failure now in systolic heart failure

play06:43

what do you notice about The ventricle

play06:45

Cooper dilated right so let's actually

play06:47

write that over here so this is a very

play06:50

dilated

play06:51

enlarged ventricle

play06:54

what you're going to notice here is that

play06:56

this is super hypertrophied this

play06:59

ventricle is very

play07:01

hypertrophied so you have what's called

play07:03

hypertrophy

play07:06

it's a very thick and large left

play07:08

ventricle we call that left ventricular

play07:10

hypertrophy or sometimes abbreviated LVH

play07:13

now the reason why is think about this

play07:16

if the pressure in the actually aorta is

play07:18

so high that you have to overcome it

play07:20

what what's one way that you can do that

play07:21

get stronger and thicken up the left

play07:24

ventricle but when you do that when you

play07:26

thicken up this left ventricle and you

play07:28

make it to where you're actually able to

play07:30

generate higher stroke volumes the

play07:31

problem is now is that you decrease the

play07:34

actual space of the left ventricle and

play07:37

now

play07:38

my problem is that I can't get the damn

play07:40

blood into the left ventricle I can't

play07:42

fill it properly and so this issue is a

play07:45

filling issue this was a forward flow

play07:48

issue

play07:49

so what do I notice here in this

play07:50

particular disease process the problem

play07:52

with diastolic heart failure

play07:55

is that they have a reduction in their

play07:57

filling process

play07:58

so there's a decrease in there left

play08:00

ventricular filling

play08:02

and because I can't fill the ventricles

play08:05

very well that's going to cause a

play08:07

problem

play08:07

now here's the thing they're left

play08:10

ventricular ejection fraction is

play08:11

completely fine it's usually completely

play08:14

preserved so this filling process won't

play08:16

affect the ejection fraction so their

play08:18

left ventricular ejection fraction is

play08:21

usually what we refer to in this case as

play08:23

normal

play08:24

or let's use the term preserved

play08:28

and so that's where we get this term a

play08:30

heart failure with a lowercase p

play08:33

preserved ejection fraction where if we

play08:36

were to give it a particular number it's

play08:38

at least greater than 40 percent so in

play08:40

these patient populations of diastolic

play08:42

heart failure their filling is reduced

play08:44

because their ventricle is super super

play08:45

hypertrophied that causes their left

play08:48

ventricular ejection fraction to be

play08:49

preserved and they have what's called a

play08:51

half path but here's the question

play08:55

this has a low cardiac output because of

play08:57

low contractility

play08:58

this will also have a low cardiac output

play09:01

you guys know why why this one will have

play09:03

a low cardiac output

play09:05

this will have a low cardiac output

play09:06

because again think about your

play09:08

physiology guys it's very very important

play09:10

to understand physiology here

play09:13

if I have a decreased filling I'm not

play09:16

going to load my ventricle very well so

play09:18

I have preload is going to drop if my

play09:20

preload drops what happens to my stroke

play09:22

volume that goes down if stroke volume

play09:23

goes down what happens to my cardiac

play09:24

output that goes down so both of these

play09:27

patients will have a low cardiac output

play09:31

but the primary difference here is that

play09:33

this is a preserved EF because they have

play09:35

no problem with the rejection fraction

play09:36

no contractility problem this one has a

play09:38

reduced ejection fraction because they

play09:40

have a contractility problem dilated

play09:42

ventricle hypertrophy ventricle super

play09:45

high yield can't forget these things

play09:47

understanding the causes high afterload

play09:49

understanding the causes contractility

play09:51

problem

play09:52

okay now we get into something that I

play09:54

think is really really important and I

play09:58

think can often be overlooked

play10:00

when patients develop heart failure

play10:02

because of these issues it can continue

play10:04

to get worse and worse and worse if not

play10:07

treated let me explain why when cardiac

play10:10

output goes down

play10:12

this is going to go back a little bit to

play10:15

your physiology here

play10:17

when cardiac output goes down

play10:19

what we know is

play10:21

there's always that formula do you guys

play10:23

remember the formula uh for blood

play10:25

pressure

play10:27

the formula for blood pressure

play10:29

is you have this one here

play10:32

that blood pressure is equal to cardiac

play10:36

output times systemic vascular

play10:37

resistance

play10:38

in patients who have heart failure

play10:40

what's the problem here

play10:42

their cardiac output drops

play10:44

and then if you were to say keeping this

play10:46

normal or constant what would happen to

play10:47

their blood pressure that would also

play10:49

drop

play10:51

so then what's the general compensatory

play10:53

mechanism that our body tries to create

play10:54

we'll do this in pink

play10:56

svr has to go up

play10:58

and so this is usually what ends up

play10:59

happening to the body is the body

play11:01

creates this weird mechanism to try to

play11:03

increase your systemic vascular

play11:04

resistance which causes a lot of

play11:06

problems let's see what that looks like

play11:09

so the reason why you may be like Zach I

play11:12

really don't want to know this this is

play11:13

kind of like foundational stuff it's

play11:15

very helpful for your pharmacology and

play11:17

understanding I promise

play11:19

so here critic output is low

play11:22

normally what this will do is a couple

play11:23

different things you know there's a

play11:25

those Barrel receptors

play11:27

and bear receptors are located in like

play11:29

your your carotids like right at the

play11:31

bifurcation or the aorta

play11:33

and they sense

play11:34

changes in cardiac output and blood

play11:36

pressure

play11:37

and so what happens is

play11:39

you're going to stimulate these things

play11:40

called Barrow receptors

play11:43

and they're going to go and they're

play11:45

going to activate

play11:47

your sympathetic nervous system

play11:49

when your sympathetic nervous system

play11:51

becomes crazy activated it's thinking to

play11:54

jack up all your epinephrine and

play11:55

norepinephrine release so then what

play11:57

you're going to see is you're going to

play11:58

see a lot of epinephrine and you're

play12:00

going to see a lot of norepinephrine

play12:02

increasing why is that a problem well

play12:05

the reason why that's a problem is is

play12:07

that these little chemicals here they

play12:09

love to go to the heart and to your

play12:12

vessels and cause some problems

play12:14

they go to the heart and they say hey

play12:16

why don't you speed up the heart rate

play12:17

because if you speed up the heart rate

play12:18

that'll increase the stroke volume

play12:19

hopefully increase the critic output but

play12:21

it's not good for a patient's heart rate

play12:22

to be super high but that's one of the

play12:24

potential compensations is you're going

play12:26

to increase the patient's heart rate

play12:28

oops sorry guys

play12:30

you're going to increase the heart rate

play12:32

and again this is because it acts on

play12:34

what's called beta 1 receptors this is

play12:36

going to become helpful I promise

play12:39

the other thing is it acts on other

play12:40

types of receptors like alpha-1

play12:42

receptors on your vasculature and causes

play12:45

it to constrict

play12:47

and if you constrict these vessels what

play12:49

happens to the diameter of them they get

play12:50

smaller what happens to the resistance

play12:53

it goes up

play12:55

so my svr will go up

play12:57

and if that happens on the artery side

play13:00

what's that going to do in my afterload

play13:02

it's going to go up

play13:03

and so it increases the afterload

play13:07

now you're like that sounds like a

play13:09

terrible thing it is terrible because

play13:12

think about this

play13:15

if a patient has

play13:17

diastolic heart failure and you increase

play13:18

their afterload what are you going to do

play13:20

you're going to worsen their diastolic

play13:22

heart failure because now if their

play13:25

afterloads High what does their body try

play13:27

to do to compensate it hypertrophes and

play13:30

it's going to worsen their already

play13:31

present heart failure so this is going

play13:33

to be it's going to trigger hypertrophy

play13:37

and guess what that's going to do that's

play13:38

going to worsen their heart failure and

play13:40

they're going to get sicker and their

play13:41

heart failure is going to get worse

play13:43

the other thing it's going to do is it's

play13:44

going to constrict the veins because

play13:45

there's alpha 1 receptors on both the

play13:47

arteries

play13:48

and there's Alpha interceptors on both

play13:49

the veins so it's going to squeeze the

play13:51

veins and try to push a lot of blood

play13:52

back to the heart

play13:53

and that's going to try to increase the

play13:55

preload

play13:57

but then if you increase the preload now

play13:58

the ventricles have to dilate to

play14:00

accommodate for that volume

play14:01

and if the ventricle dilates

play14:05

what does that sound like

play14:08

systolic heart failure so it's going to

play14:10

worsen the patient's systolic heart

play14:12

failure so this is why it sounds like

play14:13

these things are kind of like a good

play14:15

mechanism to try to increase your svr

play14:18

that's what it's trying to do

play14:20

is increase the svr to increase your

play14:22

blood pressure right

play14:24

but unfortunately it worsens the

play14:26

patient's heart failure

play14:27

and their heart rate another thing if

play14:29

that wasn't enough

play14:31

is this cardiac output is going to

play14:33

stimulate these like weird cells in the

play14:34

kidney called juxtaglomerular cells and

play14:36

these juxtapoor cells are very sensitive

play14:38

to blood pressure

play14:39

and what they'll do is they'll release a

play14:41

molecule called

play14:42

you guys already know this right ran in

play14:44

all right so it's going to release a

play14:45

molecule called renin now renin will

play14:49

then do what

play14:51

it'll then lead to the formation of

play14:53

angiotensin one Angiotensin one will

play14:56

then lead to the formation of

play14:57

angiotensin two what's the enzyme that

play14:59

stimulates that process Ace don't forget

play15:01

that

play15:02

Angiotensin II can do a couple things

play15:04

but one of those things

play15:05

is it increases aldosterone release from

play15:08

the adrenal gland

play15:10

and it also increases ADH release from

play15:13

the poster pituitary

play15:15

now with all of this being said

play15:17

what's the overall effect of all of this

play15:20

I'll show you

play15:22

Angiotensin II

play15:24

works on your vessels

play15:26

you get a lot of Angiotensin II

play15:28

receptors on your your vessels so here

play15:30

let's say we have what's called a

play15:33

Angiotensin II receptor here in your

play15:35

vessels guess what it does squeezes the

play15:37

heck out of them

play15:38

what'd that do svr goes up because

play15:41

that's the compensatory mechanism if svr

play15:44

goes up then what happens to your

play15:45

afterlook

play15:46

that goes up what happens if you have

play15:48

diastolic heart failure you worsen the

play15:49

hypertrophy patient's getting sicker

play15:51

that's not helpful

play15:53

what happens if you do the preload

play15:56

you're going to cause more blood to get

play15:57

returned to the actual heart preload

play15:59

goes up but in a patient who has

play16:01

systolic heart failure what is it going

play16:02

to do it's going to dilate their heart

play16:03

even more and worsen it so you guys get

play16:05

the concept here is that this is another

play16:07

potential problematic issue that can

play16:10

worsen the patient's heart failure and

play16:12

that's why we have drugs that we'll talk

play16:14

about a little bit later that I'm going

play16:16

to kind of preemptively kind of covering

play16:17

here that this will help to treat

play16:19

because we just don't want to have these

play16:22

high angiotensin two levels the high

play16:24

sympathetic nervous system activity and

play16:26

just to complete this concept

play16:28

aldosterone ADH will be higher and you

play16:31

know what this does this increases

play16:34

your reabsorption now the patient's

play16:37

reabsorbing lots of sodium and water

play16:40

and if you reabsorb sodium and water

play16:44

what is that going to do it's going to

play16:46

cause the patient to retain a lot of

play16:47

this fluid and they're going to start

play16:49

developing edema they'll have more

play16:50

preload so the hot ventricles will have

play16:52

to dilate more but one of the problems

play16:53

that you'll see here is they'll start

play16:55

developing a lot of Edema

play16:57

because of this

play16:59

so this is the concept that I really

play17:01

really want you guys to be able to

play17:03

understand here with this nasty disease

play17:06

process

play17:07

there's one more thing which is actually

play17:09

super cool though

play17:11

so this system here is called the renin

play17:13

angiotensinaldastrin system right you

play17:15

know whatever your heart your critic

play17:16

output is really really low

play17:18

another really interesting thing that

play17:19

happens is

play17:20

is that your heart whenever it's like

play17:23

really low cardiac output the hearts

play17:25

actually kind of get filled with blood

play17:26

and so they can release this molecule

play17:30

in response to a lot of stretch so let's

play17:32

say that the heart is really really

play17:33

being stretched it's being stretched a

play17:35

lot

play17:36

when the heart is being stretched a lot

play17:38

it makes a molecule called atrial

play17:40

natureuretic peptide and it makes a lot

play17:42

of it and the whole point of increasing

play17:45

this atrial nitritic peptide is it wants

play17:48

to go and inhibit

play17:50

the hope is that it inhibits Angiotensin

play17:53

II

play17:54

and if I inhibit Angiotensin II I

play17:57

prevent this whole disastrous process

play17:59

from occurring well that's cool I would

play18:01

really like drugs that increase amp then

play18:03

I would really like drugs that decrease

play18:05

Angiotensin II block aldosterone and

play18:09

block the sympathetic nervous system and

play18:11

that's we'll talk about in the treatment

play18:12

section but this is what I want you guys

play18:13

to understand about left heart failure

play18:15

now let's quickly go through right heart

play18:16

failure and high output failure bye my

play18:18

friend so now we got to talk about right

play18:20

heart failure so we talk about the left

play18:21

heart failure the right heart failure is

play18:22

actually a lot easier when we talk about

play18:24

right heart failures the same kind of

play18:26

concept

play18:27

we take this normal heart and we jack it

play18:29

up to cause systolic heart failure now

play18:32

when we talk about this it's again

play18:33

you're dropping what the contractility

play18:35

so what generally drops contractility on

play18:39

that right heart

play18:41

well in the left heart the most common

play18:43

cause was an MI

play18:45

guess what it would be here in mi okay

play18:47

so generally a right ventricular

play18:51

Mi is going to be the most common cause

play18:54

generally of this systolic right heart

play18:56

failure so you're dropping the

play18:58

contractility here

play18:59

and that's leading to the formation of

play19:02

the systolic heart failure now again

play19:03

what you're going to notice is that this

play19:05

puppy's going to start be getting super

play19:06

dilated all right so what you're going

play19:08

to notice is this dilated type of right

play19:10

ventricle

play19:12

now

play19:13

another concept here

play19:16

with this dilated right ventricle here

play19:18

is that your right ventricle the

play19:22

contractility is reduced right so this

play19:25

whole right ventricle let's say is

play19:27

really really messed up

play19:28

because it's messed up it's going to

play19:30

have a hard time being able to pump

play19:32

blood out into the pulmonary artery

play19:35

right so it's going to have a hard time

play19:37

with forward flow

play19:39

so what you'll notice out of these

play19:40

patients is that they're going to have a

play19:42

low right ventricular cardiac output

play19:44

right because of the contractility

play19:47

and so because of that they're going to

play19:49

have this low contractility

play19:51

this is going to lead to a decrease in

play19:54

their right ventricular ejection

play19:56

fraction

play19:58

now we don't generally give these you

play20:00

know as we compared prior the heart

play20:02

failure with the reduced ejection

play20:03

fraction that's primarily only

play20:05

consistent with left heart failure but

play20:07

again you can think about it in this

play20:08

particular way but again

play20:10

a reduction in contractility will lead

play20:13

to a reduction in the right ventricular

play20:15

ejection fraction and the problem is

play20:17

that these patients are going to have a

play20:18

hard time generating a good cardiac

play20:20

output out of the right ventricle and so

play20:22

that's the concept here it's pretty

play20:23

straightforward something is decreasing

play20:25

contractility because you infarcted the

play20:27

right ventricle

play20:29

in the other aspect over here you have

play20:31

something increasing the afterload right

play20:34

so if I have something increasing the

play20:36

afterload

play20:38

in the example for left ventricle it was

play20:41

hypertension it was aortic stenosis

play20:44

for this one it's anything that

play20:46

increases I'm going to put a little

play20:47

parentheses here anything that increases

play20:50

the pulmonary vascular resistance so for

play20:53

the art systemic circulation was called

play20:54

systemic vascular resistance that was

play20:56

hypertension oreatics aortic stenosis

play20:59

and this thing it's anything that causes

play21:01

pulmonary hypertension so we say this is

play21:05

pulmonary

play21:06

hyper

play21:08

tension and there is different types

play21:10

we'll talk about this in poem when we go

play21:13

over pulmonary hypertension but there's

play21:14

type 1 which is idiopathic type 2 which

play21:16

is due to left heart failure type 3 due

play21:19

to some type of like lung disease like

play21:20

COPD or interstitial lung disease Type 4

play21:23

due to some type of chronic pulmonary

play21:26

emboli and then type 5 is there's

play21:27

usually something like sarcoidosis like

play21:29

something compressing the pulmonary

play21:30

vascular but this is the concept I want

play21:33

you to understand pulmonary hypertension

play21:34

for right heart failure systemic

play21:36

hypertension for left heart failure for

play21:38

that diastolic type

play21:40

now what do you notice here about this

play21:42

right ventricle is thick right so they

play21:45

have some hypertrophy generally of that

play21:48

right ventricle so we could say a right

play21:49

ventricular

play21:51

hypertrophy and this is usually because

play21:53

that ventricle is going to have to

play21:56

thicken to be able to accommodate the

play21:58

high pressure of the pulmonary

play21:59

vasculature that's the only way it can

play22:01

do it

play22:02

and so because of that it's going to

play22:04

have a hard time being able to fill with

play22:06

blood so the problem with this situation

play22:09

here is the same concept they have a

play22:11

reduction and right ventricular filling

play22:14

which caused them to have a again a

play22:17

normal ejection fraction they don't have

play22:19

a problem with their ejection fraction

play22:21

so they have a normal

play22:23

right ventricular ejection fracture so

play22:25

again decreased filling process

play22:29

but normal right ventricular ejection

play22:32

fraction that's the big kind of thing

play22:34

that I want you guys to understand here

play22:36

now again remember both of these are

play22:39

going to have a reduction in right

play22:40

ventricular cardiac output it's just

play22:42

again the mechanism behind them

play22:44

developing this

play22:45

all right that covers this one for right

play22:47

heart failure the pathophysiology and

play22:49

the causes

play22:50

what about this weird one there's this

play22:53

weird entity called high output heart

play22:55

failure and generally high output heart

play22:57

failure is particularly only consistent

play22:59

with generally left so the left heart

play23:02

and what I want to do quickly is talk

play23:03

about this one so for the most part what

play23:05

you've noticed is that when we talk

play23:06

about left heart failure before is that

play23:09

there was a low cardiac output and then

play23:11

would you talk about right heart failure

play23:12

there's a low cardiac output

play23:15

there's this weird entity in the world

play23:17

where this is called a high cardiac

play23:19

output heart failure like what that

play23:21

seems odd

play23:22

it is weird but here's let me let me

play23:24

kind of explain why this happens

play23:26

and this patient here we see that their

play23:28

vessels are super dilated

play23:31

so they have extremely super vasodilated

play23:34

blood vessels so what you'll notice here

play23:36

out of these patients is they have a

play23:38

massive

play23:39

vasodilation all right and when you

play23:42

vasodilate vessels that's a big ding

play23:45

we'll talk about what causes this but

play23:46

this is massive

play23:51

vasodilation right so there is massive

play23:53

vasodilation here

play23:56

the question that you have to ask

play23:57

yourself is what's causing these vessels

play23:59

to become super super dilated and

play24:02

there's a bunch of different things

play24:04

one reason is very common is sepsis

play24:08

sepsis will cause massive vasodilation

play24:11

another one which is an odd one is when

play24:14

you have thymine deficiencies such as

play24:15

berry berry this will for some reason

play24:18

cause massive vasodilation

play24:21

thyrotoxicosis so when patient has

play24:22

thyroid storm this can also cause

play24:26

massive acetylation

play24:28

other kind of interesting things could

play24:30

be things like AV fistulas

play24:33

as well as severe and I mean really

play24:35

really severe anemia these are

play24:38

particular things that in these diseases

play24:41

but I would say sepsis being kind of one

play24:42

of the most common ones these will cause

play24:44

massive vasodilation

play24:47

when you massively visually dilate these

play24:49

vessels what happens to the systemic

play24:52

vascular resistance now soccer's huge

play24:54

resistance has got to be low

play24:57

so now there's systemic vascular

play24:59

resistance

play25:00

is crazy crazy low

play25:04

now go back to that formula what was the

play25:06

formula called

play25:07

for everything with low or how output

play25:09

heart failure we said that we have blood

play25:12

pressure is equal to cardiac output time

play25:14

systemic vascular resistance and all the

play25:16

ones that we talked about cardiac output

play25:18

was low which dropped the blood pressure

play25:19

now in this disease process

play25:22

the systemic vascular resistance is low

play25:24

which will cause the blood pressure to

play25:26

be low what has to compensate the

play25:28

cardiac output and that's why we call

play25:30

this high output heart failure

play25:34

so then what happens is when your

play25:35

systemic vascular resistance drops what

play25:37

it does is it creates a reflex kind of

play25:40

situation here so what it does it'll

play25:41

drop the blood pressure

play25:43

So the patient's blood pressure may drop

play25:46

when you drop the patient's blood

play25:48

pressure what that's going to do is it's

play25:50

going to activate the sympathetic

play25:52

nervous system and the renin

play25:53

angiotensinaldosterone system

play25:55

and that is going to increase the

play25:58

sympathetic nervous system

play26:00

now look at this

play26:02

if I increase the sympathetic nervous

play26:04

system that's then going to go in work

play26:07

on the heart

play26:09

and when it goes and works on the heart

play26:10

it's going to work on a bunch of

play26:11

different components here

play26:13

one is you have your SE node your AV

play26:17

node your bundles of hiss and bundle

play26:19

branches that's all going to be

play26:21

activated and your heart rate

play26:23

is going to try to go up because it's

play26:25

going to hopefully try to increase your

play26:26

cardiac output

play26:27

and you're going to contract your heart

play26:30

like a son of a gun so then on top of

play26:32

that you're going to try to cause the

play26:33

heart to really really contract in the

play26:35

stroke volume will go up

play26:38

and both of these are going to be an

play26:39

attempt to try to push as much blood

play26:41

possible out of the heart

play26:43

so what you'll notice here is that these

play26:45

patients will have a massive increase in

play26:47

their heart rate and a massive increase

play26:49

in their stroke volume

play26:51

but here's what's really odd

play26:54

you would think okay these guys are

play26:56

pumping and I mean pumping

play26:59

blood out of their heart into the

play27:02

coronary I mean into the systemic

play27:03

circulation so the cardiac output has to

play27:06

be high enough right it's got to be good

play27:08

enough to be able to meet the actual

play27:09

tissue demands

play27:11

it's not

play27:13

and that's where the problem here in the

play27:14

cycle occurs this disease causes

play27:16

vasodilation leads to this whole process

play27:18

tries to increase the cardiac output but

play27:21

no matter what it's not enough to meet

play27:23

the body's demands and so what happens

play27:25

here is it's not

play27:27

enough

play27:30

and that's the issue so you see how we

play27:32

talk about heart failure

play27:34

it's the inability

play27:37

to perfuse the tissues and meet their

play27:39

demands

play27:40

that would be a definition then so high

play27:43

output heart failures the cardiac

play27:44

output's high but it's not high enough

play27:46

to overcome this massive vasodilatory

play27:49

effect to meet the tissue's oxygen

play27:51

demands and that is heart failure so so

play27:53

far we've gone over left heart failure

play27:55

low output right heart failure low

play27:57

output and the Rarity of high output

play28:00

heart failure now let's go over what are

play28:02

the complications of a patient

play28:04

developing heart failure all right my

play28:06

friends so now if a patient has left

play28:08

heart failure whether that's diastolic

play28:10

or systolic heart failure or right heart

play28:12

failure whether it's systolic or

play28:13

diastolic heart failure we have to

play28:16

understand the particular complications

play28:18

that can arise

play28:19

when a patient has left heart failure

play28:21

one of the big things that you'll see

play28:23

with these patients is features of

play28:24

pulmonary congestion so either way the

play28:27

patient's cardiac output stinks they're

play28:28

not able to not get enough blood out of

play28:30

their left ventricle

play28:32

so what happens is because they have a

play28:35

cardiac output that is being reduced if

play28:38

you will in other words and these

play28:40

patients it's hard to get the blood out

play28:43

of the heart because of why because they

play28:46

have a reduced cardiac output

play28:48

now because of that

play28:51

if the blood can't get out of the heart

play28:53

where is it going to go it's going to

play28:55

start backing up into the left atrium

play28:58

when it backs up into the left atrium it

play29:00

goes into all of these like cute little

play29:01

pulmonary veins here you see it starts

play29:04

moving into the pulmonary veins and then

play29:05

what happens is it starts kind of like

play29:07

congesting these pulmonary veins

play29:09

intensely now when the pulmonary veins

play29:12

start coming very very filled with all

play29:15

of this Blood the pressure in those go

play29:17

up

play29:18

and we specifically use a terminology

play29:20

here called pulmonary capillary wedge

play29:22

pressure so we'll use that on both of

play29:24

these here and this will go up and the

play29:27

pulmonary capillary wedge pressure is a

play29:29

measure of left heart pressures so if

play29:31

the left heart pressure is high the

play29:33

pulmonary capillary wedge pressures will

play29:34

also be high

play29:36

when that happens the pressure in the

play29:38

pulmonary capillaries rise enough that

play29:41

guess what starts leaking out of these

play29:43

actual vasculature fluid so you're going

play29:46

to have fluid leaking out of this

play29:48

vasculature and into the interstitial

play29:50

spaces

play29:52

and into the alveoli so now this alveoli

play29:54

is going to become filled with fluid

play29:56

you're going to develop some edema here

play29:58

in the interstitial spaces and now these

play30:00

patients have pulmonary edema and so

play30:03

this is one of the potential

play30:04

complications is they get a little bit

play30:06

of pulmonary edema

play30:09

now why is that bad when you have

play30:12

pulmonary edema some patients can

play30:15

present a couple different ways

play30:17

one is they particularly present with

play30:20

what's called

play30:21

dyspnea now dyspnea it may just be a

play30:24

generalized Disney this may be with

play30:26

exertion this may be at rest and that

play30:29

depends upon the severity of their CHF

play30:31

but another very interesting

play30:32

presentation is that whenever these

play30:34

patients lie flat the fluid tends to

play30:37

kind of like kind of separate out into

play30:41

multiple parts of the lungs normally

play30:43

they'll be in the dependent inferior

play30:44

portions but as you lay flat this edema

play30:47

can become worse and spread throughout

play30:48

multiple alveoli and this can worsen

play30:51

their actual shortness of breath when

play30:53

they're laying flat and so there's two

play30:55

terminologies one is called proximal

play30:58

nocturnal dyspnea this is whenever

play31:00

they're at their sleep and they're

play31:01

laying flat they're super short of

play31:03

breath or just in general maybe they're

play31:05

not sleeping they're laying down flat or

play31:06

laying on a recliner and they have some

play31:08

shortness of breath there it's the same

play31:10

concept it's called orthopnia These are

play31:14

big big common features that we see with

play31:16

pulmonary edema one is just dyspnea

play31:18

whether it be exertion or rest or the

play31:20

other one is when they're laying flat

play31:21

proximal nocturnal dyspnea orthopnia

play31:25

another potential problem here

play31:28

is that whenever these patients let's

play31:30

say they really really have a massive

play31:34

reduction so let's say that their

play31:35

cardiac output massively reduces maybe

play31:37

for whatever reason common triggers for

play31:39

patients to develop what's called acute

play31:41

decompensated heart failure

play31:43

is they have an MI or they have a

play31:45

massive tachyarrhythmia or they stop

play31:47

taking their their medications they're

play31:49

supposed to be taking and what this does

play31:52

is this massively drops the cardiac

play31:53

output massively increases the pulmonary

play31:55

capillary wedge pressure and worsens

play31:57

their pulmonary edema like terribly and

play32:00

sometimes this pulmonary edema can be

play32:02

severe I'm talking severe

play32:06

pulmonary edema

play32:08

and this is something that we would

play32:10

generally see when a patient has what's

play32:11

called acute decompensated heart failure

play32:15

and what happens is is this fluid

play32:18

will really start kind of like like all

play32:21

over multiple different alveoli and

play32:24

interstitial spaces will become filled

play32:26

with fluid

play32:27

and this can cause a massive VQ mismatch

play32:30

when you fill up multiple alveoli with

play32:32

fluid that causes a VQ mismatch decrease

play32:34

in ventilation normal perfusion there's

play32:36

a mismatch and that leads to hypoxemia

play32:38

so watch out for a VQ mismatch here

play32:42

and what will happen is the patient's

play32:43

spo2 will be very low and they can

play32:46

exhibit features of what's called

play32:47

hypoxia

play32:49

the other thing is that this fluid that

play32:52

leaks into the interstitial spaces

play32:54

when it actually does leak there

play32:56

sometimes it may just cause the patient

play32:58

to have generalized dyspnea or increased

play33:01

work of breathing so they may be working

play33:02

hard to breathe or they may have a

play33:04

higher respiratory rate so that's

play33:05

another kind of thing that you want to

play33:06

watch out for is watch out for

play33:09

an increased work of breathing

play33:12

or

play33:13

an increased respiratory rate

play33:17

so these are some of the big findings

play33:18

that you want to watch out for so again

play33:20

watch out for a stimulation of VQ

play33:21

mismatch

play33:23

because of all of these alveoli being

play33:24

filled with fluid and then hypoxia so

play33:27

watch their O2 sat to see if they have

play33:29

desaturations

play33:30

this is super super common in left heart

play33:33

failure so big things to look out for is

play33:35

go to the patient see if they have any

play33:37

respiratory distress or hypoxia on their

play33:39

O2 saturation ask them if you have any

play33:42

shortness of breath at rest exertion or

play33:44

they're laying down flatter when they're

play33:45

sleeping the other thing get your

play33:47

stethoscope that you paid so much money

play33:49

for and go and listen and see if you

play33:51

hear any rails or crackles all of these

play33:54

are potential signs of pulmonary edema

play33:56

this is very common in left heart

play33:58

failure

play33:59

the scariest complication that I say

play34:01

that you would potentially see in a

play34:03

patient who has left heart failures

play34:04

cardiogenic shock and this is definitely

play34:06

the scariest one generally again a very

play34:08

common trigger here

play34:10

that can happen is an MI a massive tachy

play34:13

arrhythmia or you stop taking your

play34:15

medications these are very very common

play34:17

triggers now again same concept the

play34:20

patient has a massive drop in their

play34:23

cardiac output

play34:25

if you drop their cardiac output you're

play34:28

not going to be getting enough blood

play34:29

flow

play34:31

out of their heart

play34:32

when you don't get enough blood flow out

play34:34

of the heart particularly enough volume

play34:36

you drop that cardiac output what

play34:38

happens to their perfusion oh that's

play34:41

stinky that systemic perfusion goes down

play34:45

so not only whenever you have a low

play34:48

cardiac output do you have a hard time

play34:49

getting blood out of the heart and it

play34:51

backs up into the lungs but you have a

play34:52

hard time getting it out of the heart

play34:53

and delivering it to multiple tissues

play34:56

when you have a decrease in systemic

play34:57

perfusion

play34:59

the problem with this is

play35:01

that your body kind of says okay

play35:04

perfusion is kind of stinky right now

play35:05

the credit that's because the cardiac

play35:07

output is really low

play35:09

you know what the body tries to do is it

play35:12

says okay what I'm going to do is if the

play35:14

cardiac output is low what's that

play35:15

formula BP is equal to cardiac output

play35:17

times the systemic vascular resistance

play35:19

let's write that out so BP is equal to

play35:22

cardiac output times the systemic

play35:23

vascular resistance and these patients

play35:25

who are in cardiogenic shock this is low

play35:27

causing this to be low what has to

play35:29

compensate my friends

play35:31

svr and this will shoot through the roof

play35:34

and when svr goes up it's clamps down on

play35:38

your vessels squeezes them and now you

play35:41

have very little blood flow going to

play35:43

your extremities you know what this is

play35:45

going to do this is going to cause these

play35:47

patients to have very cold

play35:49

or pale

play35:51

extremities

play35:53

another really really terrifying sign

play35:55

here is they have like modeling this is

play35:58

really really kind of scary it's where

play35:59

they have this weird kind of

play36:00

discoloration usually at the knees and

play36:02

that's a very sign of that's a very poor

play36:04

sign of perfusion and this is usually

play36:07

because you're clamping down on those

play36:08

vessels to compensate

play36:10

another thing is that when you have

play36:11

decreased systemic perfusion not only do

play36:13

you create this reflexive

play36:14

vasoconstriction

play36:16

but you also get organ malperfusion

play36:19

right if I have organ malperfusion oh

play36:22

man that ain't good because now I'm not

play36:25

perfusing various tissues what are some

play36:28

of these tissues that actually become

play36:30

effective because of an increase in more

play36:32

organ malperfusion one is the brain the

play36:35

brain is super sensitive to blood

play36:36

pressure the coronary circulation which

play36:38

supplies The myocardium of the heart

play36:40

well it's going to make things a lot

play36:41

worse it becomes very susceptible

play36:43

the kidneys become susceptible and the

play36:46

git would probably be the last one of

play36:48

the line but it's also super susceptible

play36:51

if I don't perfuse the actual brain you

play36:53

know then I can develop encephalopathy

play36:56

and this is probably going to be one of

play36:58

the most common causes sometimes if the

play37:01

actual mouth perfusion is severe enough

play37:03

it's possible it could cause a TIA CVA

play37:07

all right that's another thing you want

play37:09

to watch out for

play37:10

the other thing is that if you don't

play37:11

profuse the actual myocardium well

play37:13

enough it may cause a myocardial

play37:16

infarction

play37:17

so you may see things like an n stand me

play37:19

or a stemi potentially so these are

play37:21

things that I think are really really

play37:22

important to remember

play37:24

the other thing is it may stimulate son

play37:26

of a gum it may stimulate injury to the

play37:29

kidneys this is called an Aki there is a

play37:33

very common terminology that you may

play37:35

hear here when patients have very severe

play37:37

left heart failure and they don't

play37:39

perfuse their kidneys very well because

play37:41

of decreased systemic perfusion but also

play37:43

their cvps are really high so it's hard

play37:45

to get blood out of the kidney they can

play37:47

develop kind of something called

play37:48

cardiorenal syndrome very common trigger

play37:51

of Aki so don't forget that one and the

play37:53

last one is they may cause

play37:55

acute mesenteric ischemia this is

play37:59

another really really big one or

play38:01

ischemic colitis and this is another big

play38:04

trigger so you're going to want to watch

play38:05

out for any kind of like bowel ischemia

play38:07

and abdominal pain

play38:08

the last thing that's always a feature

play38:11

of systemic perfusion that's being very

play38:13

very poor is your tissues whenever

play38:15

there's very little oxygens being

play38:17

delivered to the tissues so here this

play38:19

tissue is supposed to be getting oxygen

play38:20

if it's getting very very little oxygen

play38:22

they do not like that and what they do

play38:25

is they trigger the production of a

play38:27

molecule that's usually a sign of poor

play38:29

perfusion you guys know what that's

play38:30

called lactic acid but lactic acid gets

play38:33

broken down into lactate

play38:34

and so you want to watch out for this

play38:36

because one of the things that this will

play38:37

do is this will really cause the pH to

play38:40

drop and it'll trigger an acidosis so

play38:43

watch out for acidoses that can occur in

play38:46

the setting of cardiogenic shock

play38:48

so again

play38:49

when a patient has heart failure it can

play38:51

kind of look a little bit different the

play38:53

patient may have chronic CHF where their

play38:55

primary symptom may just be dyspnea

play38:57

peroxism nocturnal dyspnea orthopnia

play39:01

but if they develop an acute

play39:04

decompensated heart failure from those

play39:06

triggers Mi tachyarrhea is medication

play39:09

non-compliance they can develop severe

play39:11

pulmonary edema hypoxia respiratory

play39:13

distress

play39:14

and most patients who have

play39:16

chronic CHF they may just have minimal

play39:19

decreased systemic perfusion and the way

play39:21

that they compensate is an increase in

play39:23

systemic vascular resistance so they may

play39:25

have cold kind of pale modeled

play39:27

extremities

play39:28

but whenever it's really bad to where

play39:31

there is an acute decompensated heart

play39:33

failure due to an MI tachyarrhythmias

play39:36

medication non-compliance now they don't

play39:38

perfuse multiple organs and they can

play39:40

develop things like encephalopathy Mi

play39:42

Aki and acute mesenteric ischemia and

play39:45

lactic acidosis these are big things to

play39:47

think about my friends

play39:48

all right we come to the last one here

play39:51

patient has right heart failure all

play39:53

right so the patient is Right heart

play39:54

failure was because they had something

play39:56

wrong with the contractility or the high

play39:58

after the pulmonary hypertension this

play40:00

one's super easy thank goodness

play40:03

whenever the right heart is Damaged

play40:06

what happens is again the whole concept

play40:09

here is that it's either you can't fill

play40:10

it or you can't get blood out of it

play40:12

right so that's either one of those

play40:13

Concepts you can't get blood in or you

play40:16

can't get blood out of it

play40:18

when that happens

play40:20

what happens is the pressure in the

play40:22

right heart increases and we use a

play40:24

terminology to really describe that and

play40:27

that's called your central venous

play40:29

pressure so your central venous pressure

play40:31

becomes very high

play40:33

when your central venous pressure is

play40:35

high what happens is the blood is is

play40:38

kind of a measure of the blood backing

play40:40

up into your superior vena cava

play40:43

and blood backing up into your

play40:46

inferior vena cava and what this will do

play40:49

is this will kind of present in two

play40:51

different ways that you want to try to

play40:52

look for

play40:53

one is it'll present with a patient

play40:54

having a lot of jugular venous

play40:56

distension so they'll have a plump

play40:58

jugular vein

play40:59

and the other one is they'll have some

play41:01

edema of their lower extremities usually

play41:04

what's called pitting edema so when you

play41:06

press on it it kind of really dips in

play41:08

and gives this kind of deformity there

play41:10

this is super common in right heart

play41:12

failure

play41:13

another common presentation again

play41:16

regardless of the type whether it's

play41:19

problem filling or problem getting out

play41:21

the concept is the same is that you have

play41:25

a very high

play41:27

central venous pressure

play41:29

when your central venous pressure is

play41:31

high the blood is going to back up into

play41:32

the inferior vena cava and what it does

play41:35

is it causes one particular problem

play41:36

which leads to hepatic

play41:38

congestion

play41:40

so you know the liver I'm kind of

play41:42

zooming in on a basic model of the liver

play41:44

let's say this is a liver cell this is

play41:46

an artery this is the hepatic veins

play41:49

which empty into the IVC and this is a

play41:51

biliary duct

play41:52

whenever this hepatic vein is congested

play41:56

and it can't get blood to go up it

play41:58

congests in the liver and causes the

play42:00

liver to become injured and damaged and

play42:04

you know what this could potentially

play42:05

present as this could cause a patient to

play42:07

develop liver failure more specifically

play42:10

I would say you see this more commonly

play42:12

as a serotic kind of presentation but

play42:15

you can see this as a potential trigger

play42:17

of liver failure because of the

play42:19

increased hepatic congestion

play42:21

all right the other thing that it can do

play42:24

is it can increase your portal pressure

play42:26

so what happens is your hepatic veins

play42:28

what happens it can actually cause this

play42:30

to really cause the portal pressure

play42:31

within the venous circulation the

play42:33

hepatic portal circulation to become

play42:34

very very high

play42:36

so if you increase your portal

play42:39

pressure what this does is this causes

play42:42

the hydrostatic pressure in the portal

play42:44

veins and the peritoneal capillaries to

play42:46

be super high and leak fluid into the

play42:48

abdomen and when you leak this fluid

play42:50

into the abdomen what do we call this

play42:52

type of fluid that leaks into the

play42:54

abdomen ascites and so that's another

play42:57

very very common presentation here is

play43:00

ascites

play43:01

so watch out if a patient develops liver

play43:03

failure and they have a history of right

play43:06

heart failure think about that if they

play43:07

have ascites and they have a history of

play43:09

right heart failure think about that and

play43:10

again if they have very plump jugular

play43:12

veins and pitting edema think about a

play43:13

right heart failure

play43:15

and the last one

play43:16

it's not commonly thought of but it can

play43:19

happen left heart failure we talked

play43:20

about cardiogenic shock right heart

play43:22

failure can also get cardiogenic shock

play43:25

so think about this this concept is

play43:27

super interesting

play43:29

in this situation here you're having

play43:31

let's say blood difficulty this is more

play43:34

common in the systolic types where the

play43:37

right ventricle is super dilated in this

play43:39

situation you have problem getting blood

play43:41

out of the right heart

play43:43

and because of that

play43:45

now this right ventricle has a hard time

play43:48

if it becomes super dilated maybe it

play43:50

can't fill properly or it just can't get

play43:53

blood out of the heart

play43:54

when that happens

play43:57

because you can't get blood out of the

play43:58

heart the right ventricle

play44:00

dilates even more so if it's dilated

play44:03

before it dilates more

play44:05

all right

play44:06

so now this sucker is huge so whenever

play44:09

this happens you can't get blood out of

play44:10

the heart it's going to stimulate the

play44:11

right ventricle to dilate even more

play44:13

when the right ventricle dilates more

play44:16

the next thing it does is is it causes

play44:18

the septum

play44:20

to Bow over into the left ventricle and

play44:24

now look at the space of the left

play44:25

ventricle it's smaller so then it causes

play44:28

it's called a septal shift so a septal

play44:32

shift and we'll say that this septal

play44:34

shift is occurring from right to left

play44:36

from the right side to the left side

play44:38

what that does is

play44:40

it makes it hard for the left ventricle

play44:42

to fill with blood because now it's much

play44:44

smaller

play44:45

if it can't fill with blood what happens

play44:47

to the left ventricular cardiac output

play44:49

it drops

play44:51

so now you have a septal shift and

play44:53

that's going to cause a decrease in the

play44:56

left ventricular

play44:57

filling

play45:00

if you decrease the left ventricular

play45:02

filling

play45:03

that is going to then do what

play45:05

that is going to decrease the left

play45:07

ventricular cardiac output

play45:09

and if you decrease the left ventricular

play45:11

cardiac output oh son of a gun

play45:13

that can potentially lead to systemic

play45:16

malperfusion and then if we go on

play45:18

further

play45:19

cardio

play45:21

genic

play45:23

shock

play45:25

so this is a pretty scary one I'm

play45:27

actually usually we don't see this one

play45:29

too often right heart failure causing

play45:30

cardiogenic shock but when you do it's

play45:32

pretty terrifying because it's a really

play45:33

really bad one

play45:34

but this is another potential one that I

play45:36

want you to think about but you really

play45:38

primarily only see this one

play45:41

with right ventricular Mi as the

play45:44

particular etiology here not so much the

play45:47

pulmonary hypertension causes

play45:49

all right my friends that covers the

play45:51

issues or complications if you will of

play45:54

heart failure it's a pretty disastrous

play45:55

thing if it gets really really bad what

play45:57

I want to do now is I want to take you

play45:59

through how to diagnose heart failure

play46:01

first thing is get a chest x-ray this

play46:04

will help you because if they have

play46:05

cardiomegaly that's somewhat helpful do

play46:07

they have pleural effusions pulmonary

play46:09

edema and curly B lines that's all

play46:10

suggestive of left heart failure for the

play46:12

most part

play46:13

now

play46:15

with that being said if a patient has

play46:17

these findings that doesn't Define or

play46:19

determine that they have heart failure I

play46:21

want to combine oh they have pulmonary

play46:23

edema pleural effusions is their left

play46:25

heart not doing a good job

play46:28

well one way I could say if their heart

play46:30

is not doing a good job is I can check

play46:31

BMP this is not a good test though it's

play46:33

usually used in the emergency department

play46:35

to kind of quickly exclude a CHF

play46:37

exacerbation because if BNP levels are

play46:39

really low then you can say Okay their

play46:40

Disney is probably not from a CHF

play46:42

exacerbation if it is really high then

play46:44

you can't rule that out the better test

play46:47

as an echocardiogram because it's going

play46:49

to look directly at the heart and it's

play46:51

going to look to say hey what's the

play46:52

rejection fraction is it less than 40

play46:54

percent their left ventricle doesn't

play46:55

look like it's moving at all that's

play46:57

systolic heart failure or does it look

play46:59

like the left ventricle is Contracting

play47:01

and pumping but it's not filling

play47:03

properly oh that's diastolic heart

play47:04

failure in combination with the chest

play47:07

x-ray that can be very beneficial also

play47:09

do your physical exam if you don't see

play47:11

anything on the chest x-ray look at the

play47:13

jvd look at the legs look at the abdomen

play47:16

to look to see if they have any features

play47:17

of systemic congestion and combine that

play47:19

with their Echo

play47:21

after you've done that you should be

play47:23

able to determine is it right versus

play47:24

left that's pretty straightforward

play47:27

now the most definitively diagnostic

play47:30

test to determine if the patient is in

play47:32

acute left heart failure or in left

play47:34

heart failure in general is to do a

play47:36

right heart catheterization also

play47:37

referred to as a swan guns catheter you

play47:39

take a catheter you run it down the IJ

play47:41

you run it into the pulmonary into the

play47:43

right atrium into the pulmonary artery

play47:44

and up into these like pulmonary artery

play47:46

capillary areas inflate the balloon and

play47:49

then measure the pressures

play47:51

I told you that the pulmonary capillary

play47:53

wedge pressure if it's really high

play47:54

that's very suggestive of failure of the

play47:57

left heart

play47:58

and if it's greater than 18 millimeters

play47:59

of mercury that's a very suggestive

play48:01

number of left heart failure so if a

play48:03

patient has elevated B and P levels and

play48:04

Echo and a pulmonary capillar wedge

play48:06

pressure greater than 18 in combination

play48:08

with a chest x-ray suggestive of

play48:10

pulmonary edema I can really be

play48:12

confident in them having left heart

play48:13

failure

play48:14

now with that being said if a patient

play48:16

has acute left heart failure it's

play48:17

important to go through their medication

play48:18

list and look to see what their heart

play48:20

rate is and look to see if they have any

play48:22

valvular disturbances but one of the big

play48:24

ones that I have to do is get an EKG and

play48:26

also consider a left heart cath if I

play48:27

think they're having an MI because

play48:29

that's going to find the occlusion and

play48:30

then treat that and that might be the

play48:31

thing that knocks them out of this acute

play48:33

heart failure potentially

play48:35

all right how do we treat heart failure

play48:37

this is a really really important topic

play48:39

when I treat them I specifically went

play48:42

into this for a reason I want to reduce

play48:43

sympathetic nervous system activity

play48:45

reduce Razz activity and increase amp

play48:47

activity and if you remember increasing

play48:49

amp activity did what decrease Razz so

play48:52

my goal is to decrease sympathetic

play48:54

increase decrease sympathetic and

play48:56

decrease Razz how do I do that

play48:59

well if I decrease my sympathetic

play49:01

nervous system I have to use things like

play49:03

beta blockers and sglt2 Inhibitors so

play49:05

metoprolol Carvedilol or impact of

play49:08

losing usually these sglt2 Inhibitors

play49:10

are very very important patients with

play49:12

diabetes but if they have cardiovascular

play49:13

disease it's also beneficial and what

play49:15

happens is they reduce the sympathetic

play49:17

nervous system that reduces the heart

play49:19

rate and that also reduces the systemic

play49:20

vascular resistance I don't constrict

play49:22

the veins I don't constrict the arteries

play49:23

as much I don't reduce I don't actually

play49:25

cause changes in preload and afterload

play49:27

and I don't cause ventricular remodeling

play49:29

that improves ventricular function

play49:31

that's mortality beneficial right there

play49:34

the other thing is that sglt2 Inhibitors

play49:36

also cause aquauresis they Cause you to

play49:38

pee out of tons of water and so that can

play49:39

help with a lot of the edema if the

play49:41

patient is edematus

play49:43

the next concept is I want to reduce

play49:44

Razz activity so the reason why is one

play49:46

of our low cardiac output again we said

play49:48

increased sympathetic and low credit

play49:50

output activate renin

play49:52

so renin leads to eventually Angiotensin

play49:55

II but if I give them a drug called an

play49:57

Ace inhibitor that blocks Angiotensin 1

play49:58

from being converted into Angiotensin II

play50:01

if I also give them a drug like an AR

play50:04

and I that increases amp it prevents amp

play50:06

from being degraded if amp builds up it

play50:09

shuts down Angiotensin II and then if I

play50:12

also give an ARB our blocks Angiotensin

play50:15

II from binding to receptors all three

play50:17

of these drugs will help to decrease

play50:18

Angiotensin II if I decrease Angiotensin

play50:21

2 I reduce the constrictions of the

play50:24

arteries in the veins and I have reduced

play50:25

ventricular modeling and that's a

play50:26

mortality benefit

play50:28

another thing is Angiotensin II if

play50:30

there's less of it there's less

play50:31

aldosterone and also ADH but

play50:34

particularly aldosterone because now

play50:35

there's less sodium and water retention

play50:37

if I don't retain as much sodium in

play50:39

water I don't have as much edema but I

play50:40

also don't have as much preload and I

play50:42

don't cause ventricular remodeling

play50:44

that's where aldosterone antagonists

play50:46

would be really really beneficial in

play50:47

shutting down aldosterone production

play50:49

this is the concept and these are the

play50:51

drugs that we have to incorporate in

play50:52

patients who have heart failure because

play50:54

they have mortality reducing benefits

play50:56

okay that's a part of our guideline

play50:58

directed medical therapy

play50:59

other things that we can add on with

play51:01

guideline directed medical therapy is

play51:03

Alternatives so if patients

play51:05

African-American they can't tolerate an

play51:06

ace inhibit or an ARB hydralazine and

play51:08

isosorbide nitrate is a good combo to

play51:10

add because they're good vasodilators

play51:13

the other one is an alternative to a

play51:15

beta blocker if they're maxed on a beta

play51:17

blocker and they are a normal sinus

play51:18

rhythm I have a braiding can be

play51:20

considered

play51:22

if you want to help them to get rid of a

play51:24

lot of the sodium and water retention

play51:25

you can make them pee it out by giving

play51:27

them diuretics Loop Diuretics and

play51:28

thiazide diuretics

play51:30

and then the next thing is if a patient

play51:32

has the need for device therapy

play51:34

so what I mean by this is if a patient

play51:36

has heart failure especially left heart

play51:37

failure it stretches out the left

play51:39

ventricle and kind of causes left bundle

play51:41

branch blocks and then that alters the

play51:43

synchrony of the ventricles if I give

play51:45

them what's called a CRT cardiac

play51:47

resynchronization therapy it'll make

play51:48

sure that the ventricles are Contracting

play51:50

kind of in Tandem and improve

play51:52

potentially the left ventricular

play51:54

ejection fraction I should definitely be

play51:56

instituting that in patients with an

play51:58

lvef less than 35 percent in an lbb B

play52:02

all right that's a CRT

play52:05

if a patient has a left ventricular

play52:07

ejection fraction less than 35 percent

play52:09

and they have ventricular arrhythmias

play52:10

they need to get an aicd this will shock

play52:13

them if they go into vtac or into v-fib

play52:15

and prevent them from going into cardiac

play52:16

arrest

play52:18

the next thing is if a patient is on all

play52:20

these medications they have device

play52:22

therapy their left ventricular ejection

play52:24

fractions less than 25 percent they're

play52:25

not looking good and they look like

play52:27

they're going to need a transplant

play52:28

sometimes we will play something called

play52:29

an lvat a left ventricular assist device

play52:31

which will take blood from their left

play52:33

ventricle and shunt in a different

play52:34

direction into the aorta to give that

play52:36

left ventricle some time to rest

play52:38

now

play52:39

and patients who are in cardiogenic

play52:42

shock all right they're systemic

play52:45

perfusion stinks I want to have one

play52:49

primary goal which is to increase

play52:51

systemic perfusion so increasing

play52:53

systemic perfusion is very beneficial in

play52:54

patients who are in cardiogenic shock so

play52:57

what could I do ionotropes or mechanical

play53:00

circulatory support

play53:02

one way I can do that is I give them

play53:04

things like dobutamine or melanoma these

play53:06

are commonly used in acute decompensated

play53:08

heart failure cardiogenic shock

play53:11

the benefit of these is that they reduce

play53:12

afterload and increase contractility

play53:15

which combined increased cardiac output

play53:17

the downside is that evidence has shown

play53:19

no reduction in mortality

play53:21

the other drug is digoxin this is an

play53:23

oral and IV drug so you can take this

play53:25

outpatient you can't take these

play53:27

outpatient

play53:28

this you can give to the patient and

play53:31

it's been shown to increase

play53:31

contractility and decrease AV node

play53:33

conduction so it's good in atrial

play53:34

fibrillation as well

play53:36

it is not shown to reduce mortality but

play53:38

it may reduce the actual

play53:39

hospitalizations so there's a potential

play53:41

benefit to digoxin and increasing

play53:43

perfusion especially in patients with

play53:44

cardiogenic shock and even as an

play53:47

outpatient continuing that drug

play53:49

if the patient is failing these

play53:51

inotropes and they're continuing to

play53:52

decompensate and showing signs of

play53:54

potential failure then we go to device

play53:55

therapy and there's two ways that we

play53:57

could go here an intraoric balloon pump

play53:59

has been shown to at least preserve

play54:00

coronary perfusion so this sucker

play54:02

deflates during systole to get blood to

play54:04

go forward and then it actually inflates

play54:06

during diastole so here during diastole

play54:08

it inflates and it keeps the pressure

play54:11

all here and they order really high and

play54:14

what that does is guess what comes right

play54:15

off the aorta here the coronary arteries

play54:17

so if the pressure is high in the order

play54:19

during diastole it's going to improve

play54:20

coronary perfusion and improve

play54:22

myocardial contractility and that's the

play54:24

benefit of this

play54:26

most times patients who end up on

play54:29

cardiogenic shock refractory to a lot of

play54:31

medications such as dobedamine mil

play54:33

Renown androtic balloon pumps may

play54:35

require something called VA ECMO this is

play54:38

called venal arterial extracorportal

play54:40

membrane oxygenation we take a catheter

play54:41

we run it into one of their veins we run

play54:44

it out of the vein and into a pump from

play54:46

there we run it through an oxygenator

play54:48

and then we put it in a catheter that

play54:49

runs right into their artery these are

play54:51

Big stinking catheters and they are

play54:53

designed to be able to help to maintain

play54:54

a decent amount of flow and augment the

play54:56

cardiac output and also oxygenate the

play54:59

blood so this is a potential beneficial

play55:01

therapy that could be used as a patient

play55:02

refractory cardiogenic shock

play55:05

the other thing I think that's important

play55:06

to remember in a patient who's in

play55:07

cardiogenic shock or having any signs of

play55:10

cardiogenic pulmonary edema is what's

play55:12

called BiPAP using diuretics to help to

play55:15

get rid of some of the sodium and water

play55:16

which will help to reduce some of that

play55:18

actual pulmonary edema but BiPAP has

play55:20

been shown to potentially increased

play55:22

answer thoracic pressure and that will

play55:24

help to reduce right ventricular preload

play55:26

so you don't have as much blood going to

play55:27

the right heart and you don't have as

play55:28

much blood going out of the right heart

play55:29

so now less blood is going through the

play55:31

pulmonary circulation and going to the

play55:33

left heart if there's left blood less

play55:34

blood going that way that's going to

play55:36

have less blood leaking out into the

play55:37

pulmonary interstitium less pulmonary

play55:40

edema

play55:41

the other concept is it drops your left

play55:43

ventricular afterload so the pressure in

play55:44

the orders drops so it's easier to get

play55:46

blood out of the left ventricle into the

play55:47

aorta so you have less blood coming to

play55:49

the left heart and you have more blood

play55:51

going out of the left heart that's going

play55:53

to improve your cardiac output and

play55:55

reduce pulmonary edema but more

play55:57

particularly reduce pulmonary edema and

play55:59

that's one of the benefits of this drug

play56:01

in patients who are in acute heart

play56:02

failure or potentially cardiogenic shock

play56:05

all right I know this is a lot let's go

play56:07

through this in a systematic approach a

play56:09

patient comes in they have heart failure

play56:11

you've changed their modifiable risk

play56:13

factors after that you start them on an

play56:16

Ace inhibitor or an ARB all right plus a

play56:18

beta blocker they're still symptomatic

play56:20

give them diuretics to reduce venous

play56:22

congestion whether systemic or pulmonary

play56:24

they're still symptomatic add-on

play56:26

aldosterone antagonist and an sglt2

play56:28

inhibitor

play56:29

they're still symptomatic

play56:31

and they're potentially unable to

play56:34

tolerate an Ace inhibitor in ARB well

play56:36

switch them switch to an AR and I if

play56:39

possible so an Angiotensin receptor

play56:42

neprolysin inhibitor

play56:43

so this would be things where you put

play56:45

them on like succubutril

play56:47

um valzartan so these are very good

play56:49

drugs that have been shown to be very

play56:50

beneficial

play56:51

the other thing is if they can't do that

play56:54

one or if they're African-American

play56:55

consider hydralazine and isosorbide

play56:58

nitrate it actually has a mortality

play56:59

benefit

play57:00

if the patients are symptomatic on all

play57:02

these therapies and in normal sinus

play57:04

rhythm maxed out on a beta blocker give

play57:06

them either braiding

play57:07

if the patient has a left ventricular

play57:09

ejection fraction less than 35 percent

play57:12

and a left bundle branch block or a QRS

play57:15

greater than 120 give them cardiac

play57:17

resynchronization therapy

play57:19

if despite all of these measures they

play57:21

remain symptomatic

play57:22

try to increase their perfusion usually

play57:26

inotropes would be the next step here so

play57:29

digoxin would probably be the one that

play57:30

you'd want to continue outpatient if

play57:32

they're an overt cardiogenic shock male

play57:34

Renown or dobutamine

play57:36

and then from there if you have to

play57:38

Mechanical circulatory support if

play57:40

they're an overt cardiogenic shock

play57:41

intriotic Bloom pumps via ECMO hopefully

play57:44

they recover and then the thing that you

play57:46

would need to put them on to bridge them

play57:48

to a transplant is an lvad and hopefully

play57:51

they would get a cardiac transplant and

play57:53

improve

play57:54

all right my friends that covers heart

play57:56

failure I hope it made sense I hope that

play57:57

you guys enjoyed it and as always until

play57:58

next time

play58:03

[Music]

play58:15

thank you

Rate This

5.0 / 5 (0 votes)

Etiquetas Relacionadas
Heart FailureClinical MedicineSystolic FailureDiastolic FailureCardiac OutputMedical EducationPathophysiologyCardiologyPulmonary EdemaCardiogenic Shock
¿Necesitas un resumen en inglés?